SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-009023
Filing Date
2017-08-14
Accepted
2017-08-11 21:08:58
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 895835
2 ex31-1.htm EX-31.1 11751
3 ex32-1.htm EX-32.1 4851
  Complete submission text file 0001493152-17-009023.txt   3933253

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE mrna-20170630.xml EX-101.INS 544064
5 XBRL SCHEMA FILE mrna-20170630.xsd EX-101.SCH 44280
6 XBRL CALCULATION FILE mrna-20170630_cal.xml EX-101.CAL 42867
7 XBRL DEFINITION FILE mrna-20170630_def.xml EX-101.DEF 213199
8 XBRL LABEL FILE mrna-20170630_lab.xml EX-101.LAB 323452
9 XBRL PRESENTATION FILE mrna-20170630_pre.xml EX-101.PRE 268474
Mailing Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748
Business Address 17870 CASTLETON STREET SUITE 250 CITY OF INDUSTRY CA 91748 4259083600
Marina Biotech, Inc. (Filer) CIK: 0000737207 (see all company filings)

IRS No.: 112658569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-13789 | Film No.: 171026614
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1